arrow
Z

Zarif K. Jabbar-Lopez

University of London
H指数:15
被引数:1,092

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis

奈莫珠单抗治疗结节性痒疹长达100周: 奥林匹亚LTE中期分析

2025-12-010
OAAI
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis The OLYMPIA 1 Randomized Clinical Phase 3 Trial

中重度结节性痒疹患者中Nemolizumab的疗效与安全性:OLYMPIA 1随机临床试验(III期)

2025-02-014
PRE
Nemolizumab monotherapy was associated with significant improvements in prurigo activity score in adult patients with moderate-to-severe prurigo nodularis: results from a phase 3 trial (OLYMPIA 2)
2023-06-203
PRE